| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0474
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 |
| filingDate |
2017-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d850fc8f0e9722c1ef6abf1c04a64d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4a16b9e8da4332a7371c76dfcffc942
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d4bf2df772d36a5754682076c37abd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6997c02183490f2a0e51a6c7125afefe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4acf3e5b95c068724eb9c33d70d027aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56a42b4d9802b81aedcb428efceffb29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5251d3ad44b37d7238fb554587a926a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ecded2e067d1ab5f9551c2f64cb6742 |
| publicationDate |
2022-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2912947-T3 |
| titleOfInvention |
Nuclear imaging and radiotherapeutic agents targeting carbonic anhydrase IX and uses thereof |
| abstract |
A compound of formula (IVc or IVd): **(See formula)** or **(See formula)** wherein: B is a metal chelating moiety optionally comprising a metal or a radiometal, or a prosthetic group halogenated or radiohalogenated; or a pharmaceutically acceptable salt thereof. |
| priorityDate |
2016-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |